Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236893 · ClinicalTrials.gov registry record · NA
Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository
A NA study, sponsored by Seed Health.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06236893 is a NA study that has completed, run by Seed Health. The registered enrollment target is 200 participants.
The verdict
NCT06236893, a NA study, has completed, sponsored by Seed Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of a personal care product on vaginal health in individuals with a self-reported history of vaginal discomforts such as malodor, bothersome discharge, itching, irritation, and dryness. The personal care product, VH-01 contains a prebiotic and three distinct strains of Lactobacillus crispatus, a microbe commonly found in healthy vaginal microbiomes. The study will be a randomized, placebo-controlled trial where the test product will be compared to a placebo in a 2:1 manner. Participants will be asked to complete online questionnaires and provide vaginal samples to assess microbial communities. The aims of this study are to assess: 1. The user experience and acceptability of VH-01 vaginal suppository vs. placebo. 2. Attitudes and perceptions of VH-01 vaginal suppository usage vs. placebo. 3. Health-related quality of life during the use of VH-01 vaginal suppository vs. placebo. 4. Changes in self-perceived vaginal discomforts during the use of VH-01 vaginal suppository vs. placebo.
Interventions
- OTHER VH-01 vaginal suppository tablet
- OTHER Placebo vaginal suppository tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236893
The ClinicalTrials.gov registry entry for NCT06236893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seed Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VH-01 vaginal suppository tablet is the first listed.
NCT06236893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06236893 about?
NCT06236893 is a clinical study titled "Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository". The purpose of this study is to assess the impact of a personal care product on vaginal health in individuals with a self-reported history of vaginal discomforts such as malodor, bothersome discharge, itching, irritation, and dryness. The personal care product, VH-01 contains a prebiotic and three d...
What is the current status of trial NCT06236893?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-29. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT06236893?
The interventions under investigation include: VH-01 vaginal suppository tablet (OTHER), Placebo vaginal suppository tablet (OTHER).
Who is sponsoring clinical trial NCT06236893?
This trial is sponsored by Seed Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.